Biblio Discovery — Demo Discovery Service

3 hasil untuk "Simurdic Petar"

Menampilkan 1–3 · 1,73 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Independent Predictors Associated with Patient Refusal of Invasive Diagnostic Procedures After Positive LDCT Lung Cancer Screening

    Zaric, Bojan; Djekic Malbasa, Jelena; Kovacevic, Tomi dkk.

    Diagnostics (Basel) · 2026 · Inggris · PubMed Central

    Background: Low-dose computed tomography (LDCT) screening reduces lung cancer mortality; however, the effectiveness of screening programs depends not only on detection, but also on completion of downstream diagnostic pathways following a positive screening result. Refusal of recommended invasive…

  2. Artikel Jurnal Teks lengkap

    Attitudes toward Death among Health Care Professionals in the Balkan Region

    Kovacevic, Tomi; Zaric, Bojan; Djekic Malbasa, Jelena dkk.

    Curr Oncol · 2024 · Inggris · PubMed Central

    Background and Objectives: Death is an unavoidable experience in any person’s life and affects not only the dying person but also their caregivers. The dying process has been displaced from homes to health care facilities in the majority of cases. Facing death and dying has become an everyday life…

  3. Artikel Jurnal

    Real-world data survival outcomes of first line immunotherapy with pembrolizumab in high expressers with stage IV non-small cell lung cancer

    Stojsic Vladimir; Zaric Bojan; Simurdic Petar dkk.

    Radiology and Oncology, Vol. 60 No. 3 · 2026 · Inggris · DOAJ Scopus

    Pembrolizumab monotherapy is standard of care in first line treatment of patients with stage IV lung cancer and programmed death ligand 1 (PD-L1) expression ≥ 50%. Whether the higher levels of PD-L1 expression predict higher benefit from the treatment with pembrolizumab is still debatable.